The Sr Director, Translational Pathology will oversee capabilities transformation and translational pathology strategy across multiple drug programs and indications. They will work to bring new technologies and approaches to patient selection and pharmacodynamic biomarkers for Oncology and Specialty Medicine programs. Responsibilities include a focus on digital pathology investigations, exploratory biomarker investigations including integration of pathology datasets with broader multi-omic analyses, and technical oversight for CDx programs. The successful candidate will work effectively in a highly collaborative environment, aligning with key counterparts within Pathology, Translational Science, Bioinformatics, and Companion Diagnostics in the US and Japan. The position includes direct report management.
Education Qualifications
Experience Qualifications
Ability to travel up to 10% of the time. global travel
Daiichi Sankyo, Inc. is an equal opportunity/affirmative action employer. Qualified applicants will receive consideration for employment without regard to sex, gender identity, sexual orientation, race, color, religion, national origin, disability, protected veteran status, age, or any other characteristic protected by law.
USD$217,500.00 – USD$362,500.00
#J-18808-Ljbffr
